Impact of recommended maternal vaccination programs on the clinical presentation of sars-cov-2 infection: A prospective observational study

Biblos-e Archivo/Manakin Repository

Show simple item record de la Cruz Conty, Maria Luisa Encinas Pardilla, Maria Begoña Garcia Sanchez, Marta Gonzalez Rodriguez, Laura Muner-Hernando, Marta Luisa Royuela Vicente, Ana Pintado Recarte, Pilar Martinez Varea, Alicia Martinez Diago, Clara Cruz Melguizo, Sara Martinez-Perez, Oscar
dc.contributor.other UAM. Departamento de Obstetricia y Ginecología es_ES 2021-09-14T17:15:22Z 2021-09-14T17:15:22Z 2021-01-08
dc.identifier.citation Vaccines 9.1 (2021): 31 en_US
dc.identifier.issn 2076-393X es_ES
dc.description.abstract The COVID-19 pandemic has raised questions about the possible cross immunity resulting from common vaccination programs and SARS-CoV-2 infection. Therefore, the Spanish Obstetric Emergency group performed a multicenter prospective study on the vaccination status of Influenza and Tdap (diphtheria, tetanus and pertussis vaccine boost administered in adulthood) in consecutive cases of SARS-CoV-2 infection in a pregnancy cohort, in order to assess its possible association with the clinical presentation and severity of symptoms of SARS-CoV-2 infection, as well as to determine the factors that may affect vaccination adherence. A total of 1150 SARS-CoV-2 positive pregnant women from 78 Spanish hospitals were analyzed: 183 had not received either vaccine, 23 had been vaccinated for Influenza only, 529 for Tdap only and 415 received both vaccines. No association was observed between the vaccination status and the clinical presentation of SARS-CoV-2 infection and/or the severity of symptoms. However, a lower adherence to the administration of both vaccines was observed in the Latin-American subgroup. Based on the results above, we reinforce the importance of maternal vaccination programs in the actual pandemic. Health education campaigns should be specially targeted to groups less likely to participate in these programs, as well as for a future SARS-CoV-2 vaccination campaign. en_US
dc.description.sponsorship This research was supported by public funds obtained in competitive calls: Grant COV20/ 00021 from the Instituto de Salud Carlos III-Spanish Ministry of Health, and co-financed with Fondo Europeo de Desarrollo Regional (FEDER) funds en_US
dc.format.extent 10 pag. es_ES
dc.format.mimetype application/pdf en
dc.language.iso eng en_US
dc.publisher MDPI, Basel, Switzerland en_US
dc.relation.ispartof Vaccines en_US
dc.rights © 2021 The authors es_ES
dc.subject.other Covid 19 es_ES
dc.subject.other Diphtheria tetanus pertussis vaccine en_US
dc.subject.other Influenza vaccines en_US
dc.subject.other Maternal immunization en_US
dc.subject.other Passive immunization en_US
dc.subject.other Pregnancy en_US
dc.subject.other SARS-CoV-2 en_US
dc.title Impact of recommended maternal vaccination programs on the clinical presentation of sars-cov-2 infection: A prospective observational study en_US
dc.type article en
dc.subject.eciencia Medicina es_ES
dc.relation.publisherversion es_ES
dc.identifier.doi 10.3390/vaccines9010031 es_ES
dc.identifier.publicationfirstpage 31-1 es_ES
dc.identifier.publicationissue 1 es_ES
dc.identifier.publicationlastpage 31-10 es_ES
dc.identifier.publicationvolume 9 es_ES
dc.relation.projectID Gobierno de España. COV20/00021 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion en Reconocimiento es_ES
dc.rights.accessRights openAccess en
dc.authorUAM Martínez Pérez, Oscar (271125)

Files in this item


This item appears in the following Collection(s)

Show simple item record